Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.17B |
| 2 |
Netflix
NFLX
|
+$753M |
| 3 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$749M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$662M |
| 5 |
Walmart Inc
WMT
|
+$405M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.08B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$426M |
| 3 |
Meta Platforms (Facebook)
META
|
+$372M |
| 4 |
TSMC
TSM
|
+$331M |
| 5 |
Pinduoduo
PDD
|
+$319M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.23% |
| 2 | Technology | 1.7% |
| 3 | Consumer Discretionary | 0.84% |
| 4 | Communication Services | 0.67% |
| 5 | Financials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11926
PUT
Ovid Therapeutics
OVID
$562M
| $23.3K | ﹤0.01% |
+14,300
| New | +$22K |
|
11927
CALL
Agilon Health
AGL
$1.6B
| $23.2K | ﹤0.01% |
1,344
-9,252
| -87% | -$179K |
|
11928
CALL
Offerpad Solutions
OPAD
$21.8M
| $23.1K | ﹤0.01% |
1,910
-35,920
| -95% | -$795K |
|
11929
CALL
Caribou Biosciences
CRBU
$178M
| $22.7K | ﹤0.01% |
14,300
-7,600
| -35% | -$16K |
|
11930
PUT
Atossa Therapeutics
ATOS
$26.2M
| $22.7K | ﹤0.01% |
2,567
+94
| +4% | +$1.19K |
|
|
UCL
11931
uCloudlink Group
UCL
$14.5M
| $22.6K | ﹤0.01% |
13,528
-8,571
| -39% | -$18K |
|
11932
Polar Power
POLA
$6.19M
| $22.6K | ﹤0.01% |
+13,509
| New | +$41.7K |
|
|
CISO
11933
CISO Global
CISO
$10.5M
| $22.1K | ﹤0.01% |
46,086
+20,511
| +80% | +$16.8K |
|
11934
Compugen
CGEN
$259M
| $22.1K | ﹤0.01% |
14,439
-2,663
| -16% | -$4.42K |
|
11935
PUT
FingerMotion
FNGR
$11M
| $22K | ﹤0.01% |
17,900
+900
| +5% | +$1.34K |
|
11936
Duluth Holdings
DLTH
$143M
| $22K | ﹤0.01% |
10,557
-72,993
| -87% | -$216K |
|
11937
MAIA Biotechnology
MAIA
$84.6M
| $21.9K | ﹤0.01% |
14,288
+2,673
| +23% | +$3.49K |
|
|
IH
11938
iHuman
IH
$68.5M
| $21.6K | ﹤0.01% |
+10,304
| New | +$27.3K |
|
|
OPENW
11939
Opendoor Technologies Inc Series K Warrants
OPENW
$6.94M
| $21.6K | ﹤0.01% |
+24,014
| New | +$32.4K |
|
|
OLPX
11940
PUT
DELISTED
Olaplex Holdings
OLPX
| $21.6K | ﹤0.01% |
16,100
+4,700
| +41% | +$5.59K |
|
11941
AgEagle Aerial Systems
UAVS
$69.8M
| $21.5K | ﹤0.01% |
+26,381
| New | +$41K |
|
|
NOTE
11942
PUT
DELISTED
FiscalNote
NOTE
| $21.5K | ﹤0.01% |
14,600
-185,000
| -93% | -$562K |
|
11943
GigaMedia
GIGM
$15.8M
| $21.4K | ﹤0.01% |
14,366
+1,352
| +10% | +$2.12K |
|
11944
PUT
MacroGenics
MGNX
$262M
| $21.3K | ﹤0.01% |
13,200
-53,400
| -80% | -$84K |
|
|
VBIO
11945
Valion Bio
VBIO
$496K
| $21.2K | ﹤0.01% |
+14,639
| New | +$33.4K |
|
|
SUIG
11946
PUT
Sui Group Holdings
SUIG
$77.6M
| $21.2K | ﹤0.01% |
12,700
-16,100
| -56% | -$41.6K |
|
|
GRMLW
11947
Greenland Mines Ltd Warrant
GRMLW
| $21.1K | ﹤0.01% |
217,879
-39,975
| -16% | -$6K |
|
|
ZENV
11948
DELISTED
Zenvia
ZENV
| $21.1K | ﹤0.01% |
+21,913
| New | +$27.9K |
|
11949
Phio Pharmaceuticals
PHIO
$13.1M
| $21.1K | ﹤0.01% |
+20,091
| New | +$32.1K |
|
|
ABVE
11950
PUT
DELISTED
Above Food Ingredients Inc
ABVE
| $21K | ﹤0.01% |
+12,900
| New | +$38.6K |
|
Similar funds
Jeff Yass's Q4 2025 Portfolio in Review
As of Q4 2025, Jeff Yass held 14,094 positions worth $868B, down 0.79% from $875B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2025 filing shows 1,864 new, 4,890 increased, 5,380 reduced and 1,914 closed positions. Its largest new stake was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.08B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2025 buy was iShares Core MSCI Total International Stock ETF: 1,468,872 shares worth $124M.
- Jeff Yass added most to Invesco QQQ Trust in Q4 2025, an estimated $1.17B increase.
- Jeff Yass's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.08B.
- Jeff Yass fully exited Innovator US Equity Power Buffer ETF September in Q4 2025, selling an estimated $26.5M.
- Jeff Yass's ten largest holdings make up 24% of its $868B portfolio in Q4 2025.
- Jeff Yass opened 1,864 new positions and closed 1,914 in Q4 2025.
- Jeff Yass's portfolio value fell 0.79% quarter-over-quarter to $868B.
Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.